This is the authors' abstract. We don't add key points for this paper.
In this work, we design an asymmetric hetero-trimetallic single-atom catalyst with ZnN 3 CoN 3 FeN 2 S active catalytic sites to enhance the oxygen reaction performances.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: